We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $7.48B
1-Year Est. Return 104.76%
This Fund
S&P 500
This Quarter Est. Return
+37.69%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$7.48B
AUM Growth
+$1.44B
Cap. Flow
-$77.6M
Cap. Flow %
-1.04%
Top 10 Hldgs %
23.83%
Holding
336
New
58
Increased
161
Reduced
69
Closed
35
Avg Time Held
6.6 quarters
Top 10 Avg Time Held
4.2 quarters
Top 20 Avg Time Held
4.6 quarters

Top Buys

Rank Stock Value
1
AVLN icon
Avalyn Pharma
AVLN
+$39.7M
2
CDNS icon
Cadence Design Systems
CDNS
+$29.6M
3
RELY icon
Remitly
RELY
+$27.3M
4
DELL icon
Dell
DELL
+$25.5M
5
FITB icon
Fifth Third Bancorp
FITB
+$25.3M

Top Sells

Rank Stock Value
1
XMTR icon
Xometry
XMTR
+$57.8M
2
PLD icon
Prologis
PLD
+$56.1M
3
GH icon
Guardant Health
GH
+$44M
4
AXSM icon
Axsome Therapeutics
AXSM
+$44M
5
GLBE icon
Global E Online
GLBE
+$37.6M

Sector Composition

Rank Sector Weight
1 Healthcare 36.37%
2 Technology 22.57%
3 Industrials 20.48%
4 Energy 5.51%
5 Utilities 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MAX icon
326
MediaAlpha
MAX
$562M
– –
-17,509
Closed -$165K –
OCS icon
327
Oculis Holding
OCS
$469M
– –
-430,000
Closed -$11.4M –
OKTA icon
328
Okta
OKTA
$39.9B
– –
-4,505
Closed -$340K –
PATH icon
329
UiPath
PATH
$7.01B
– –
-10,716
Closed -$116K –
PATK icon
330
Patrick Industries
PATK
$2.06B
– –
-2,265
Closed -$239K –
PCOR icon
331
Procore
PCOR
$8.59B
– –
-5,490
Closed -$306K –
PLD icon
332
Prologis
PLD
$127B
– –
-427,133
Closed -$56.1M –
VEEV icon
333
Veeva Systems
VEEV
$49.6B
– –
-3,066
Closed -$539K –
VO icon
334
Vanguard Morningstar Mid-Cap ETF
VO
$107B
– –
-9,612
Closed -$690K –
WDS icon
335
Woodside Energy
WDS
$44B
– –
-11,923
Closed -$289K –
BBOT icon
336
BridgeBio Oncology
BBOT
$242M
– –
-541,181
Closed -$4.7M –

Similar funds

Eventide Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, Eventide Asset Management held 336 positions worth $7.48B, up 24% from $6.05B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management's Q2 2026 filing shows 58 new, 161 increased, 69 reduced and 35 closed positions. Its largest new stake was Avalyn Pharma: 1,375,486 shares worth $45.3M. The largest sale was Xometry, an estimated $57.8M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q2 2026 buy was Avalyn Pharma: 1,375,486 shares worth $45.3M.
  • Eventide Asset Management added most to Cadence Design Systems in Q2 2026, an estimated $29.6M increase.
  • Eventide Asset Management's biggest Q2 2026 reduction was Xometry, cutting an estimated $57.8M.
  • Eventide Asset Management fully exited Prologis in Q2 2026, selling an estimated $56.1M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $7.48B portfolio in Q2 2026.
  • Eventide Asset Management opened 58 new positions and closed 35 in Q2 2026.
  • Eventide Asset Management's portfolio value rose 24% quarter-over-quarter to $7.48B.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.